罕见神经系统疾病治疗市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00008485
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Rare Neurological Disease Treatment Market Scope 2031

Buy Now

2021年罕见神经疾病治疗市场估值为76亿美元,预计到2031年将达到145亿美元。预计2023年至2031年该市场的复合年增长率为8.7%。治疗罕见神经系统疾病的临床试验和药物研究可能仍然是罕见神经系统疾病治疗市场的关键趋势。

 

罕见神经疾病治疗市场分析

 

创新疗法罕见神经系统疾病治疗

药物评价与研究中心 (CDER) 宣布于 2023 年批准第一种酶替代疗法,用于治疗 α-甘露糖苷贮积症(一种罕见的遗传性溶酶体贮积症)的非神经系统影响。此外,2024 年 3 月,一项临床研究发现,一种研究性基因疗法可能有助于患有罕见神经退行性疾病的患者。此外,2022 年 5 月,加速罕见病治愈 (ARC) 计划成立,旨在推动科学和监管创新和参与,以加快罕见病患者获得治疗的速度。 FDA 将利用 ARC 项目的基础设施、专业知识和战略领导力来建立一个中心间罕见神经退行性疾病工作组。上述因素对 2021-2031 年罕见神经疾病治疗市场的增长具有影响力。

 

罕见神经疾病治疗市场概述

技术、创新和智能技术解决方案等继续对罕见神经疾病治疗市场产生重大影响。创新疗法罕见神经疾病治疗和产品发布是罕见神经疾病治疗市场增长的最有影响力的因素。治疗罕见神经疾病的临床试验和药物研究是罕见神经疾病治疗市场增长的关键趋势。不断增加的研发(R&D)活动将提供利润丰厚的市场机会。

 

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

罕见神经疾病治疗市场:

罕见神经疾病治疗市场
  • Rare Neurological Disease Treatment Market
    年均复合增长率(2023 - 2031)
    8.7%
  • 2021 年市场规模
    76 亿美元
  • 2031 年市场规模
    145 亿美元

市场动态

增长动力
  • 创新疗法罕见神经系统疾病治疗
未来的趋势
  • 治疗罕见神经系统疾病的临床试验和药物研究
机会
  • 产品推出迎合市场

关键人物;主力;重要一员

  • 艾尔建(艾伯维)公司,
  • 拜耳公司,
  • 葛兰素史克公司,
  • 强生服务公司,
  • 默克公司,
  • 诺华公司,
  • 辉瑞公司,
  • 赛诺菲,
  • 梯瓦制药工业有限公司,
  • 武田制药,

区域概况

Rare Neurological Disease Treatment Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Rare Neurological Disease Treatment Market指示
  • 发作性睡病
  • 肌萎缩侧索硬化症
  • 阿尔茨海默氏病
  • 多发性硬化症
  • 脊髓性肌肉萎缩症
  • 杜氏肌营养不良症
  • 其他的
Rare Neurological Disease Treatment Market药品类型
  • 有机化合物
  • 生物制品
Rare Neurological Disease Treatment Market管理方式
  • 口服
  • 可注射
Rare Neurological Disease Treatment Market分销渠道
  • 医院药房
  • 零售药店
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

罕见神经疾病治疗市场驱动因素和机遇

 

产品推出迎合市场

2022 年 11 月,CENTOGENE 宣布推出“生物数据网络”,这是一套面向生物制药和研究机构的数据驱动型罕见和神经退行性疾病产品组合。此外,CENTOGENE 数据集代表了目前通过 BC 平台提供的基因组数据的广度和深度估计增加了 20% 。该数据集反映了多样化的地理和种族样本库,包括患有罕见和神经退行性疾病的儿科病例的流行率,包括临床、多组学和社会人口统计数据。因此,此类用于罕见神经系统疾病治疗的创新产品发布数据集将在未来几年做出重大贡献。

 

不断增加的研发 (R&D) 活动——机遇

  • 2023 年 12 月,美国食品和药物管理局 (FDA) 宣布向公共和私人实体提供拨款和合同,涵盖预防、诊断、减轻、治疗和治愈肌萎缩侧索硬化症(ALS) 和其他疾病的研发 (R&D) 成本。评估成人和儿童的神经退行性疾病。
  • 2023 年 6 月,Ipsen 和 Medentia 宣布开展广泛的药物发现和药物化学合作。通过此次合作,两家公司将共同为世界各地的人们带来新的解决方案,重点关注罕见疾病,包括罕见的神经退行性疾病。

因此,不断增加的研发活动将为罕见神经疾病治疗市场提供利润丰厚的市场机会,在未来几年占据相当大的市场份额。

 

罕见神经系统疾病治疗

市场报告细分分析

有助于得出罕见神经疾病治疗市场分析的关键部分是候选和服务。

  • 根据适应症,罕见神经系统疾病治疗市场分为发作性睡病、肌萎缩侧索硬化症、阿尔茨海默病、多发性硬化症、脊髓性肌萎缩症、杜氏肌营养不良症等。到2023年,阿尔茨海默病可能会占据更大的市场份额。
  • 根据药物类型,罕见神经疾病治疗市场分为有机化合物和生物制剂。到2023年,生物制剂可能会占据更大的市场份额。
  • 根据给药方式,罕见神经疾病治疗市场分为口服和注射。到 2023 年,口服细分市场可能会占据更大的市场份额。
  • 根据分销渠道,罕见神经疾病治疗市场分为医院药房、零售药房等。到 2023 年,医院药房部门可能会占据更大的市场份额。

 

按地域划分的罕见神经疾病治疗市场份额分析

罕见神经疾病治疗市场报告的地理范围主要分为五个区域:北美、亚太地区、欧洲、中东和非洲、南美洲/南美洲和中美洲。

北美主导了罕见神经疾病治疗市场。在北美,美国在罕见神经系统疾病治疗方面占有相当大的份额。美国顶级制造商的存在和研发活动的增加是市场增长的最有影响力的因素。预计亚太地区未来几年将以最高的复合年增长率增长。  

 

罕见神经系统疾病治疗

市场报告范围

报告属性细节
2021年市场规模76亿美元
2031 年市场规模145亿美元
全球复合年增长率(2023 - 2031)8.7%
历史数据2021-2022
预测期2023-2031
涵盖的细分市场按指示
  • 发作性睡病
  • 肌萎缩侧索硬化症
  • 阿尔茨海默氏病
  • 多发性硬化症
  • 脊髓性肌肉萎缩症
  • 杜氏肌营养不良症
  • 其他的
按药物类型
  • 有机化合物
  • 生物制品
按管理方式
  • 口服
  • 可注射
按分销渠道
  • 医院药房
  • 零售药店
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 艾尔建(艾伯维)公司,
  • 拜耳公司,
  • 葛兰素史克公司,
  • 强生服务公司,
  • 默克公司,
  • 诺华公司,
  • 辉瑞公司,
  • 赛诺菲,
  • 梯瓦制药工业有限公司,
  • 武田制药,
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

罕见神经疾病治疗市场新闻和最新动态

罕见神经疾病治疗市场是通过收集初级和二级研究后的定性和定量数据进行评估的,其中包括重要的公司出版物、协会数据和数据库。以下是罕见神经疾病治疗市场的发展和策略:

  • 2022 年 9 月,美国食品和药物管理局 (USFDA) 和美国国立卫生研究院 (NIH) 宣布启动“罕见神经退行性疾病的关键路径 (CP-RND)”,这是一项公私合作伙伴关系,旨在推动罕见神经退行性疾病的关键路径对神经退行性疾病的了解,促进肌萎缩侧索硬化症 (ALS) 和其他罕见神经退行性疾病治疗方法的开发。

 

罕见神经疾病治疗市场报告范围和成果

《罕见神经疾病治疗市场规模和预测(2021-2031)》报告对以下领域的市场进行了详细分析:

  • 范围内涵盖的所有关键细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,例如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析,涵盖主要市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..